Doc On Call? Cosmetic Manufacturers May Need M.D. On Retainer Under MoCRA
Executive Summary
Cosmetic manufacturers may need to retain a medical professional to determine if adverse events they receive are minor or serious given the looming deadline for maintaining records and reporting serious adverse events to the US FDA, says Locke Lord partner David Abramowitz.
You may also be interested in...
IBA Connects Members With FDA Compliance Expert As MoCRA Deadlines Loom
The Independent Beauty Association joins with Registrar Corp to provide IBA members with expert resources for preparing for deadlines under the Modernization of Cosmetics Regulation Act.
Getting A Jump On MoCRA Compliance; Due Diligence Now Will Lighten Load, Risks Later
Cosmetics companies should not sit idly waiting for FDA to clarify new requirements under the Modernization of Cosmetic Regulations Act, speakers agreed at the Independent Beauty Association’s 2023 Technical/Regulatory Forum. Companies should be reviewing products, people and processes, including those of contract manufacturers, to get ahead of the curve.
Arcaea Resurrects Extinct Flowers With First Fragrances Under Future Society Brand; Cosmetics News
Coty and English footballer David Beckham announce a collection of eau de parfums rolling out to US retailers nationwide in January following a debut in JCPenney. Arcaea introduces biotech-based scents capturing the essence of extinct flowers, and Procter & Gamble’s Mielle hair-care brand launches its first ad campaign. More product launch and marketing news.